The proteolytic potential of normal human melanocytes: Comparison with other skin cells and melanoma cell lines

Pigment Cell Research

Volumn 9, Issue 5, 1996, Pages 255-264

  Bizik, Jozef ^a,b   Bessou, Sandrine ^a   Felnerova, Diana ^b   Vaheri, Antti ^c   Taïeb, Alain ^a,d  

^a HÔPITAL PELLEGRIN   (France)

^b CANCER RESEARCH INSTITUTE   (Slovakia)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Alpha 2 macroglobulin; Gelatinase; Urokinase receptor

Indexed keywords

ALPHA 2 MACROGLOBULIN; CELL SURFACE RECEPTOR; COLLAGEN; GELATINASE; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; KERATINOCYTE; MELANOCYTE; MELANOMA; METABOLISM; SECRETION; SKIN;

ALPHA-MACROGLOBULINS; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; GELATINASES; HUMANS; KERATINOCYTES; MELANOCYTES; MELANOMA; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; SKIN; TUMOR CELLS, CULTURED;

EID: 0030253799     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.1996.tb00115.x     Document Type: Review

References (53)

1. Backer S.W., L.L. Praver, and H. Thatcher (1935) An improved (parafilm section) method for the Dopa-reaction. Arch Dermatol Syphilol 31:190-195.
2. Bell E., B. Ivarsson, and C. Merrill (1979) Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. U.S.A., 76:1274-1278.
3. Bessou S., J.E. Surlève-Bazeille, E. Sorbier, and A. Taïeb (1995) Ex vivo reconstruction of the epidermis with melanocytes and the influence of UVB. Pigment. Cell. Res., 8:241-249.
4. Bizik J., A. Vaheri, O. Saksela, N. Kalkkinen, S. Meri, M. Grofova (1986) Human tumor cells synthesise and secrete alpha-2-macroglobulin in vitro. Int. J. Cancer, 37:81-88.
5. Bizik J., A. Lizonova, M. Grofova, J. Matoska, J.F. Doré, S. Bertrand, M. Blasko, and A. Vaheri (1989) Clonal variation in the production of tumor-associated alpha-2-macroglobulin in a malignant human melanoma and association with growth stimulation. Cancer Res., 49:983-990.
6. 2-macroglobulin secretion. Cell Reg., 1:895-905.
7. Bizik J., R.W. Stephens, M. Grofova, and A. Vaheri (1993) Binding of tissue-type plasminogen activator to human melanoma cells. J. Cell. Biochem., 51:326-335.
8. Blasi F. (1993) Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness. BioEssays, 15:105-111.
9. Boyce S.T., and R.G. Ham (1985) Normal human epidermal keratinocytes. In: In vitro models for cancer research. Weber M.M., Sekely L., eds. CRC Press, Boca Raton, pp. 245-274.
10. Burge S.M., J.R. Marshall, and S.A. Cederholm-Williams (1992) Plasminogen binding sites in normal human skin. Br. J. Dermatol., 126:35-41.
11. Donatien P., J.E. Surlève-Bazeille, A.J. Thody, and A. TaÏeb (1993) Growth and differentiation of normal human melanocytes in a TPA-free, cholera toxin-free, low-serum medium and influence of keratinocytes. Arch. Dermatol. Res., 285:385-392.
12. Eisinger M., and O. Marko (1982) Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc. Natl. Acad. Sci. U.S.A., 79:2018-2022.
13. Eisinger M., R.B. Flick, J. Bizik, and Y. Arita (1991) Epidermal cell derived factor (EDF) Partial purification and characterisation. In: Clinical and Experimental Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds, Wiley-Liss Inc., New York pp. 375-384
14. Gilehrest B.A., M.A. Vrabel, E. Flynn, and G. Szabo (1984) Selective cultivation of human melanocytes from newborn and adult epidermis. J. Invest. Dermatol., 83:370-376.
15. Gilehrest B.A., L.S. Albert, R.L. Karassik, and M. Yaar (1985) Substrate influences human epidermal melanocytes attachment and spreading in vitro. In Vitro Cell Dev. Biol., 21:114-120.
16. Green G.D.G., and E. Shaw (1979) Thiobenzyl benzyloxylcarbonyl-L-lysinate, substrate for a sensitive colorimetric assay for trypsin-like enzymes. Anal. Biochem., 93:223-227.
17. Grøndahl-Hansen J., L.R. Lund, E. Ralfkiaer, V. Ottevanger, and K. Danø (1998) Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelization in vivo. J. Invest. Dermatol., 90:790-795.
18. Hashimoto K., T. Horikoshi, K. Nishioka, K. Yoshikawa, and D.M. Carter (1986) Plasminogen activator secreted by cultured melanocytes. Br. J. Dermatol., 115:205-209.
19. Herlyn M., M.L. Mancianti, J. Jambrosic, J.B. Bolen, and H. Koprowski (1988) Regulatory factors that determine growth and phenotype of normal human melanocytes. Exp. Cell. Res., 179:322-331.
20. Heussen C., and E.B. Dowdle (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gel containing sodium dodeeyl sulfate and copolymerized substrates. Anal. Biochem., 102:196-202.
21. Houde M., G. De Bruyne, M. Bracke, M. Ingelman-Sundberg, G. Skoglund, S. Masure, J. Van Damme, and G. Opdenakker (1993) Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells. Int. J. Cancer, 53:395-400.
22. 2+ on the attachment of human melanocytes to laminin and fibronectin. Evidence for specific alpha-MSH receptor on these cells. Ann. N.Y. Acad. Sci., 680:549-551.
23. Isseroff R.R., and D.B. Rifkin (1983) Plasminogen is present in the basal layer of epidermis. J. Invest. Dermatol., 80:297-299.
24. Jensen P.J., M. John, and J. Baird (1990) Urokinase and tissue type plasminogen activator in human keratinocytes culture. Exp. Cell. Res., 187:162-169.
25. Karelina T.V., G.J. Hruza, G.I. Goldberg, A.Z. Eisen (1993) Localization of 92-kDa type IV collagenase in human skin tumors: Comparison with normal human fetal and adult skin. J. Invest. Dermatol., 100:159-165.
26. Kessler S.W. (1975) Rapid isolation of antigens from cells with a staphylococcal protein A antibody absorbent: Parameters of the interaction of antibody-antigen complexes with protein A. J. Immunol., 155:1617-1624.
27. Klaus SN (1980) Prospects for growing normal human melanoeytes in vitro. In: Methods in Cell Biology. Harris C.C., Trump B.F., Stoner G.D., eds. Academic Press, New York, pp. 277-288
28. 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganisation of collagen I fibrils. J. Cell. Biol., 115:1427-1436.
29. Krasagakis K., C. Garbe, S. Kruger, C.E. and Orfanos (1991) Effects of interferons on cultured human melanocytes in vitro: Interferon b but not a or g inhibit proliferation and all interferons significantly modulate the cell phenotype. J. Invest. Dermatol., 97:364-372.
30. Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680-685.
31. Laiho M., O. Saksela, P.A. Andreasen, J. Keski-Oja (1986) Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J. Cell. Biol., 103:2403-2410.
32. Lauharanta J., E.M. Salonen, and A. Vaheri (1989) Plasmin-like proteinase associated with high molecular weight complexes in blister fluid of bullous pemphigoid. Acta Dermatol. Venereol., 69:527-529.
33. Liotta L.A. (1984) Tumor invasion and metastases: Role of the basement membrane. Am. J. Pathol., 117:339-384.
34. Lund L.R., E. Rønne, A.L. Roldan, N. Behrendt, J. Rømer, F. Blasi, and K. Danø (1991) Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J. Biol. Chem., 266:5177-5181.
35. Mauviel A. (1993) Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem., 53:288-295.
36. Murphy G., and J.J. Reynolds (1993) Extracellular matrix degradation. Molecular, genetic and medical aspects. In: Connective Tissue and its Heritable Disorders. Royce P.M., and Steinmann B., eds. Wiley-Liss Inc., New York, pp. 287-316
37. Nerlov C., D. De Cesare, F. Pergola, A. Caracciolo, F. Blasi, M. Johnsen, and P. Verde (1992) A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J., 11:4573-4582.
38. Parekh R.B., R.A. Dwek, J.R. Thomas, G. Opdenakker, and R.W. Rademacher (1989) Cell-type-specific and site-specific N-glycosylation of type I and type II human tissue plasminogen activator. Biochemistry, 28:7644-7662.
39. Pöllänen J., R.W. Stephens, and A. Vaheri (1991) Plasminogen activation at the surface of normal and malignant cells. Adv. Cancer Res., 57:273-328.
40. Pyke C., E. Ralfkiaer, P. Huhtala, T. Hurskainen, K. Danø, and K. Tryggvason (1992) Localization of messenger RNA for Mr 72 000 and 92 000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res., 52:1336-1341.
41. Quax P.H.A., I.L.A. Boxman, C.A.M. Van Kesteren, J.H. Verheijen, and M. Ponec (1994) Plasminogen activators are involved in keratinoeyte and fibroblast migration in wounded cultures in vitro. Fibrinolysis, 8:221-228.
42. Reinartz J., R. Batrla, P. Boukamp, N. Fusenig, and M.D. Kramer (1993) Binding and activation of plasminogen at the surface of human keratinocytes. Exp. Cell. Res., 208:197-208.
43. Rønne E., N. Behrendt, M. Ploug, H.J. Nielsen, E. Wolliseh, U. Weidle, K. Danø, and G. Høyer-Hansen (1994) Quantitation of the receptor for urokinase plasminogen activator by enzyme linked immunosorbent assay. J. Immunol. Methods, 167:91-101.
44. Siracky J., M. Blasko, J. Borovansky, J. Kovarik, J. Svec, M. Vrba (1982) Human melanoma cell lines: Morphology, growth and a-mannosidase characteristics. Neoplasma, 29:661-668.
45. Sottrup-Jensen L. (1989) a-Macroglobulins: Structure, shape, and mechanism of proteinase complex formation. J. Biol. Chem., 264:11539-11542.
46. 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells. Cell Reg., 2:176-185.
47. Stetler-Stevenson W.G., L.A. Liotta, and D.E. Kleiner (1993) Extra-cellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J., 7:1434-1441.
48. Straight D.L., M.A. Hassett, and P.A. McKee 1995) Structural and functional characterisation of the inhibition of urokinase by alpha-2-macroglobulin. Biochemistry, 24:3902-3907.
49. Towbin H., T. Staehelin, and J. Gordon (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. U.S.A., 76:4350-4354.
50. Tryggvason K., M. Höytyä, and T. Salo (1987) Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta, 907:191-217.
51. Vaheri A., J. Bizik, E.M. Salonen, H. Tapiovaara, V. Siren, H. Myöhänen, and R.W. Stephens (1992a) Regulation of the pericellular activation of plasminogen and its role in tissue-destructive processes. Acta Ophthamol. K., 70:34-41.
52. Vaheri A., H. Tapiovaara, J. Bizik, V. Siren, H. Myöhänen H, T. Reisberg, A. Lymboussakis, M. Palolahti, and R. Stephens (1992B) Plasminogen activation on tumor cell surface. In: Metastasis: Basic Research and its Clinical Applications. Rabes H, Peters PE, Munk K (eds.). Contrib. Oncol., Vol. 44, Karger, Basel, pp. 127-140.
53. 2Macroglobulin in the regulation of pericellular plasminogen activation of human tumor cells. Ann. N.Y. Acad. Sci., 737:409-418.